ARPHA OAI-PMH Endpoint
metadata only
Inhibitors of sodium-glucose co-transporters in the treatment of diabetic nephropathy and chronic kidney disease: A narrative review
Background: Chronic kidney disease (CKD) is a global health problem, ranking as the 12th leading cause of disability and the 9th leading cause of death worldwide, affecting over 14% of adults. Among the causes is diabetic nephropathy (DN), a common microvascular complication of diabetes characterise
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Anti-Nephropathic Effects of Chronic Intermittent Intravenous Insulin Therapy (CIIIT)#833486
- A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients#1261811
- Metformin dosage and renal protection in type 2 diabetes mellitus: Impact on estimated glomerular filtration rate#81790
- A lipid metabolism-based gene signature defines diagnosis and molecular heterogeneity in diabetic nephropathy.#1091106
- Pancreas Allotransplantation for Diabetic Nephropathy and Mild Chronic REnal fAilure Stage Study#995592
Record · ID 1305843
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive